New data shows GSK-Vir drug works against all Omicron mutations
British drugmaker GSK said on Tuesday its antibody-based Covid-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data ...